These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Some central effects of angiotensin II. Interactions with dopaminergic transmission. Georgiev V; György L; Getova D; Markovska V Acta Physiol Pharmacol Bulg; 1985; 11(4):19-26. PubMed ID: 3012944 [TBL] [Abstract][Full Text] [Related]
7. Central action of glucagon. Morawska D; Sieklucka-Dziuba M; Kleinrok Z Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264 [TBL] [Abstract][Full Text] [Related]
8. Effects of buspirone on dopamine dependent behaviours in rats. Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392 [TBL] [Abstract][Full Text] [Related]
9. The influence of antineoplaston A5 on the central dopaminergic structures. Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388 [TBL] [Abstract][Full Text] [Related]
10. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors. Papeschi R; Randrup A Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160 [No Abstract] [Full Text] [Related]
11. Estimation of central activity of hydroxyproline--the amino acid characteristic for collagen degradation products. Wiśniewski K; Lutostańska A; Artemowicz B; Maćkowiak J Pol J Pharmacol; 1995; 47(4):285-91. PubMed ID: 8616506 [TBL] [Abstract][Full Text] [Related]
12. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs. Nohria V Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599 [No Abstract] [Full Text] [Related]
13. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment. Overstreet DH; Smee ML; Woolston ME Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554 [No Abstract] [Full Text] [Related]
14. [Diphasic action of apomorphine on motility of the rat. I. Dose-effect relationship in exploratory and basal motility]. Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N Boll Soc Ital Biol Sper; 1981 Feb; 57(4):374-80. PubMed ID: 7236417 [TBL] [Abstract][Full Text] [Related]
15. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats. Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028 [TBL] [Abstract][Full Text] [Related]
16. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system. Wawrzyniuk I; Buczko W; Wiśniewski K Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959 [TBL] [Abstract][Full Text] [Related]
17. Effects of dextromethorphan on dopamine dependent behaviours in rats. Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148 [TBL] [Abstract][Full Text] [Related]
18. Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4). Zalewska A; Winnicka MM; Wiśniewski K Pol J Pharmacol; 1996; 48(4):415-23. PubMed ID: 9112682 [TBL] [Abstract][Full Text] [Related]